Cargando…
‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
[Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047448/ https://www.ncbi.nlm.nih.gov/pubmed/35413180 http://dx.doi.org/10.1021/acs.analchem.1c05238 |
_version_ | 1784695728230105088 |
---|---|
author | Cuypers, Eva Claes, Britt S. R. Biemans, Rianne Lieuwes, Natasja G. Glunde, Kristine Dubois, Ludwig Heeren, Ron M. A. |
author_facet | Cuypers, Eva Claes, Britt S. R. Biemans, Rianne Lieuwes, Natasja G. Glunde, Kristine Dubois, Ludwig Heeren, Ron M. A. |
author_sort | Cuypers, Eva |
collection | PubMed |
description | [Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis. Here, we applied mass spectrometry imaging (MSI) to acquire and visualize the molecular profiles at the single-cell and subcellular levels of 14 different breast cancer cell lines. We built a molecular library of genetically well-characterized cell lines. Multistep processing, including deep learning, resulted in a breast cancer subtype, the cancer’s hormone status, and a genotypic recognition model based on metabolic phenotypes with cross-validation rates of up to 97%. Moreover, we applied our single-cell-based recognition models to complex tissue samples, identifying cell subtypes in tissue context within seconds during measurement. These data demonstrate “on the spot” digital pathology at the single-cell level using MSI, and they provide a framework for fast and accurate high spatial resolution diagnostics and prognostics. |
format | Online Article Text |
id | pubmed-9047448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-90474482022-04-29 ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging Cuypers, Eva Claes, Britt S. R. Biemans, Rianne Lieuwes, Natasja G. Glunde, Kristine Dubois, Ludwig Heeren, Ron M. A. Anal Chem [Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis. Here, we applied mass spectrometry imaging (MSI) to acquire and visualize the molecular profiles at the single-cell and subcellular levels of 14 different breast cancer cell lines. We built a molecular library of genetically well-characterized cell lines. Multistep processing, including deep learning, resulted in a breast cancer subtype, the cancer’s hormone status, and a genotypic recognition model based on metabolic phenotypes with cross-validation rates of up to 97%. Moreover, we applied our single-cell-based recognition models to complex tissue samples, identifying cell subtypes in tissue context within seconds during measurement. These data demonstrate “on the spot” digital pathology at the single-cell level using MSI, and they provide a framework for fast and accurate high spatial resolution diagnostics and prognostics. American Chemical Society 2022-04-12 2022-04-26 /pmc/articles/PMC9047448/ /pubmed/35413180 http://dx.doi.org/10.1021/acs.analchem.1c05238 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Cuypers, Eva Claes, Britt S. R. Biemans, Rianne Lieuwes, Natasja G. Glunde, Kristine Dubois, Ludwig Heeren, Ron M. A. ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging |
title | ‘On the Spot’ Digital Pathology of Breast
Cancer Based on Single-Cell Mass Spectrometry Imaging |
title_full | ‘On the Spot’ Digital Pathology of Breast
Cancer Based on Single-Cell Mass Spectrometry Imaging |
title_fullStr | ‘On the Spot’ Digital Pathology of Breast
Cancer Based on Single-Cell Mass Spectrometry Imaging |
title_full_unstemmed | ‘On the Spot’ Digital Pathology of Breast
Cancer Based on Single-Cell Mass Spectrometry Imaging |
title_short | ‘On the Spot’ Digital Pathology of Breast
Cancer Based on Single-Cell Mass Spectrometry Imaging |
title_sort | ‘on the spot’ digital pathology of breast
cancer based on single-cell mass spectrometry imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047448/ https://www.ncbi.nlm.nih.gov/pubmed/35413180 http://dx.doi.org/10.1021/acs.analchem.1c05238 |
work_keys_str_mv | AT cuyperseva onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT claesbrittsr onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT biemansrianne onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT lieuwesnatasjag onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT glundekristine onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT duboisludwig onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging AT heerenronma onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging |